Skip to content

Resolute Integrity™ RSINT30034UXRecalls & reported problems

Medtronic, Inc. · Stent RSINT30034UX MicroTrac 3.00X34RX · Class 3 · Implant

All models of Resolute Integrity (52)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00643169037199), received between Jan 2, 2019 and Jan 2, 2019 — classified as 1 malfunction.

The most frequently reported specific device problem is “Material Deformation” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Material Deformation1

Patient problems

  • No Consequences Or Impact To Patient1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionJan 2, 2019Material Deformation; Material Deformation

    A RESOLUTE INTEGRITY DRUG ELUTING STENT DEVICE WAS ATTEMPTED TO BE USED TO TREAT IN-STENT RESTENOSIS IN THE OM1. THE LESION WAS PRE-DILATED WITH A 2.75 X 15MM EUPHORA BALLOON CATHETER. IT IS REPORTED THAT THE STENT FAILED TO CROSS THE LESION AND STENT STRUT DAMAGE WAS SEEN ON REMOVAL OF THE DEVICE. THE PROCEDURE WAS COMPLETED USING A NON-MEDTRONIC STENT. NO PATIENT INJURY IS REPORTED.

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 8208020 ↗

Other Coronary drug-eluting stent devices

All Coronary drug-eluting stent devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page